Molecular mechanisms of FasL-mediated 'reverse-signaling'

Area of Science:

• Immunology
• Molecular Biology
• Cell Signaling

Background:

• Effector lymphocytes like NK and T cells express Fas Ligand (FasL), crucial for tumor cell killing via Fas receptor interaction.
• While FasL's role in tumor cell death is known, its intracellular signaling pathways ('reverse signaling') within effector cells remain poorly understood.
• FasL's cytoplasmic tail contains motifs suggesting complex signaling interactions.

Purpose of the Study:

• To elucidate the molecular mechanisms and signaling pathways downstream of FasL 'reverse signaling' within effector lymphocytes.
• To identify novel interacting partners of FasL's cytoplasmic tail.
• To define the functional consequences of these pathways on effector lymphocyte activity.

Main Methods:

• Bioinformatic analysis and prediction of conserved cytoplasmic domains of FasL.
• Identification of potential protein-protein interactions and signaling complex formation.
• Exploration of downstream signaling cascades including PI3K/Akt/mTOR, Ras/ERK, and CBM signalosome pathways.

Main Results:

• FasL directly interacts with PI(3)K-p85α, initiating a cascade involving PIP3, PLC-γ2, and Akt/mTOR signaling.
• A separate pathway involves FasL, GRB2, GADs, Ras-GTP, PAK1, and the ERK cascade.
• FasL recruits Fyn and ADAP, leading to the formation of the Carma1/Bcl10/Malt1 (CBM) signalosome, crucial for inflammatory cytokine production.

Conclusions:

• FasL engages in complex 'reverse signaling' within effector lymphocytes through multiple interdependent pathways.
• These pathways involve PI3K, Ras/ERK, and CBM signalosome activation, impacting immune cell function.
• Understanding these FasL-mediated signaling networks is critical for defining effector lymphocyte responses.